project year

2029

Developing a clinic-ready nanomedicine for RNA therapy for pancreatic and lung cancers

Developing Better Targeted Treatments for Adults with Hard-to-Treat Blood Cancer (B -ALL)

Evaluating new immunotherapies targeting the FAT1 cadherin in high risk leukaemia

Overcoming resistance to treat metastatic ER+ breast cancer

Precision Immune-Targeted Gene Silencing to Combat Neuroblastoma Dependency

Targeting lipid metabolism in pancreatic ductal adenocarcinoma to improve chemotherapy efficacy

Targeting obesity-related factors to enhance liver cancer therapies

Targeting RNA to stop severe inflammation in metabolic dysfunction-associated fatty liver disease and its progression to cancer

Targeting TOPORS E3 Ligase to Overcome Resistance to Hypomethylating Therapy in AML

Understanding naevus pigmentation and evolution into melanomas

Help us to put an end to cancer